Literature DB >> 8575139

CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome.

Z Kirtava1, J Blomberg, A Bredberg, G Henriksson, L Jacobsson, R Manthorpe.   

Abstract

OBJECTIVE: Primary Sjögren's syndrome (1 degree SS) is an autoimmune disease, usually accompanied by manifest immune hyperactivity. In some cases the disease converts to malignant neoplasia. On the other hand, there are clinical similarities to HIV infection. Since the rare phenomenon of persistent depletion of CD4+ T-lymphocytes in peripheral blood without HIV infection was recently defined as idiopathic CD4+ T-lymphocytopenia (ICL), we have used the ICL criteria to investigate the prevalence of this phenomenon among 1 degree SS patients.
METHODS: During the period 1988-94, 115 caucasian patients (10 males), mean age 57.8 (range 19-82) years, with 1 degree SS were prospectively studied. Lymphocyte subsets were investigated by means of monoclonal antibodies and flow cytometry. For the detection of HIV and HTLV antibodies, we used an enzyme immunoassay (for HIV-1 and HIV-2), Western blot techniques (HIV-1, HIV-2, HTLV-I and HTLV-II), and the polymerase chain reaction procedure (HIV-1, HTLV-I and HTLV-II). HIV antigens were tested for with the HIV-1 p-24 Ag test.
RESULTS: Six patients with 1 degree SS fulfilled the criteria for ICL. While the clinical condition of 5 of those six patients remained stable, one patient developed malignant lymphoma three years after her disease was classified as a case of ICL. The prevalence of ICL among our 115 patients with 1 degree SS was 5.2%, which is significantly higher than the rates reported for any other patient or population group. We have estimated the relative risk of ICL in 1 degree SS patients to vary from 3.4 to 6,000 (P values of 0.0001-0.025).
CONCLUSION: We suggest that subjects with ICL should be carefully examined for 1 degree SS and, if its presence is confirmed, that they should be followed with regard to the possible complications of this disease, including the development of malignant lymphoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575139

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Authors:  E Theander; G Henriksson; O Ljungberg; T Mandl; R Manthorpe; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

2.  Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells.

Authors:  Christina T Moses; Kristen M Thorstenson; Stephen C Jameson; Alexander Khoruts
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

Review 3.  Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells.

Authors:  Dimitrios Zonios; Virginia Sheikh; Irini Sereti
Journal:  Arthritis Res Ther       Date:  2012-08-31       Impact factor: 5.156

Review 4.  Lymphopenia and autoimmune diseases.

Authors:  Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2004-06-22       Impact factor: 5.156

5.  Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review.

Authors:  Sarmad Said; Haider Alkhateeb; Chad J Cooper; Emmanuel Rodriguez; Remi Trien; German T Hernandez; Hasan S Salameh
Journal:  Int Med Case Rep J       Date:  2014-07-30

Review 6.  The Confluence of Sex Hormones and Aging on Immunity.

Authors:  Melanie R Gubbels Bupp; Tanvi Potluri; Ashley L Fink; Sabra L Klein
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

7.  Elevated CCL19/CCR7 Expression During the Disease Process of Primary Sjögren's Syndrome.

Authors:  Zhenwei Liu; Fengxia Li; Axiao Pan; Huangqi Xue; Shan Jiang; Chengwei Zhu; Mengmeng Jin; Jinxia Fang; Xiaochun Zhu; Matthew A Brown; Xiaobing Wang
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

8.  [Lymphocytopenia: aetiology and diagnosis, when to think about idiopathic CD4(+) lymphocytopenia?].

Authors:  A Régent; N Kluger; A Bérezné; K Lassoued; L Mouthon
Journal:  Rev Med Interne       Date:  2012-05-30       Impact factor: 0.728

9.  Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases.

Authors:  Dina S Ahmad; Mohammad Esmadi; William C Steinmann
Journal:  Avicenna J Med       Date:  2013-04

Review 10.  Idiopathic CD4 Lymphocytopenia: Current Insights.

Authors:  Saravanakumari Vijayakumar; Stalin Viswanathan; Rajeswari Aghoram
Journal:  Immunotargets Ther       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.